Two Sigma Investments, LP Tyme Technologies, Inc. Transaction History

Two Sigma Investments, LP

  • $41.1 Billion
  • Q2 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.23 - $0.35 $33,509 - $50,992
-145,694 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.28 - $0.68 $40,794 - $99,071
145,694 New
145,694 $51,000
Q3 2020

Nov 16, 2020
SELL
$0.93 - $1.35 $73,970 - $107,376
-79,538 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$0.97 - $1.7 $77,151 - $135,214
79,538 New
79,538 $106,000
Q4 2019

Feb 14, 2020
SELL
$1.0 - $1.49 $16,694 - $24,874
-16,694 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$0.97 - $1.77 $55,155 - $100,643
-56,861 Reduced 77.3%
16,694 $20,000
Q2 2019

Aug 14, 2019
BUY
$0.96 - $1.89 $70,612 - $139,018
73,555 New
73,555 $90,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email